SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Patrick E.McDaniel who wrote (30)2/16/1997 2:28:00 PM
From: Haiji Xia   of 1510
 
Milestone expected for imnr:

complete enrollment of patients for phsIII trial -Remune 4Q96

initiate phs II trial Remune 4Q96

complete phs II trials Rheumatoid arthritis 4Q96

complete phs II trials psoriasis

results from complete phs I colon cancer 4Q96

complete enrollment of pediatric trial Remune 1Q97

initiate phs II multiple sclerosis 2Q97

initiate phs I trial brain cancer 2Q97

initiate phs I trial prostate cancer 2Q97

initiate phs I trial hemophilia 2Q97

complete phs II thailand trial remune 3Q97

initiate phs I trial athersclerosis 3Q97

initiate phs I trial hepatitis 4Q97
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext